Partnering to Help End the HIV Epidemic in Eastern Europe & Central Asia

Gilead recently committed an additional $25 million to the next phase of RADIAN, our collaboration with the Elton John AIDS Foundation. The initiative supports community-based action aimed at helping end the HIV epidemic in Eastern Europe and Central Asia.

Our Purpose

Scientific Innovation

We discover, develop and deliver medicines for the world’s most devastating diseases, from viruses to cancer to inflammatory conditions.

A young woman and an older woman embracing

Access & Health Equity

We’re partnering with communities around the world to remove societal barriers to care, improve health equity and make our medicines available to those who need them most.

A smiling Gilead employee in a manufacturing facility

Our People & Culture

We foster an environment of inclusion and growth where our 17,000+ employees around the world are empowered to make a real impact.

We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.

Our Mission